D-dimer as a marker for cardiovascular and arterial thrombotic events in patients with peripheral arterial disease
Peripheral artery disease (PAD) is associated with an increased risk for cardiovascular events. D-dimers are a marker for hypercoagulability and are linked with thrombotic events in patients with venous as well as arterial thrombosis. The predictive value of plasma D-dimer levels in relation to card...
Gespeichert in:
Veröffentlicht in: | Thrombosis and haemostasis 2013, Vol.110 (2), p.233-243 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 243 |
---|---|
container_issue | 2 |
container_start_page | 233 |
container_title | Thrombosis and haemostasis |
container_volume | 110 |
creator | M.-C. F. Kleinegris H. ten Cate A. J. ten Cate-Hoek |
description | Peripheral artery disease (PAD) is associated with an increased risk for cardiovascular events. D-dimers are a marker for hypercoagulability and are linked with thrombotic events in patients with venous as well as arterial thrombosis. The predictive value of plasma D-dimer levels in relation to cardiovascular events in patients with PAD is not unambiguously established. It was our objective to gather evidence evaluating the value of D-dimer as a predictor of arterial thrombotic events patients with PAD. The Pubmed, Embase, and Cochrane databases were searched (January 1980-November 2012), and 65 abstracts were found. The strategy was supplemented with manual review of reference lists. Case-control, cohort or prospective cohort studies that measured fibrin D-dimer in patients with PAD, were included. Studies were excluded if there was no follow-up for arterial thrombotic events or when no specific information on D-dimer was available. The search yielded 10 studies for our analysis, comprising 2,420 patients with PAD, with a total of 1,036 cardiovascular events in 10,599 patient-years. Two studies with a follow-up of one year showed that fibrin D-dimer predicts both deterioration of PAD and subsequent thrombotic events. Five out of six studies with a median follow-up of 2–4 years revealed that an increased D-dimer is predictive of various arterial thrombotic events including mortality. Two studies with a longer follow-up (over 6 years) did not show an independent association between increased D-dimer levels, arterial thrombotic events and CVD mortality. In conclusion, an increased D-dimer appeared to be independently associated with a two times increased risk of near-term cardiovascular events (relative risk 2.30, 95% confidence interval 1.43–3.68). However formal meta-analysis was only feasible for four out of 10 included studies. Due to the extended heterogeneity of the included studies cautious interpretation of these data is warranted. |
doi_str_mv | 10.1160/TH13-01-0032 |
format | Article |
fullrecord | <record><control><sourceid>thieme_schat</sourceid><recordid>TN_cdi_thieme_journals_10_1160_TH13_01_0032</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1160_TH13_01_0032</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3452-90533d2ca46d5fa5ae92f2ae79bf1bd79e53ab0a0f7b2a2d078036a566a3fe4f3</originalsourceid><addsrcrecordid>eNq9kMtqHTEMhk1pIKdpdnkA78u0vow9Z5YlvaQQ6CaF7oTG1mCnZy7YnhP69vU0oY_QlST0Sz__x9iNFO-ltOLDw53UjZCNEFq9YgdlbNfYY__zNTsI3YrGqtZcsjc5PwohbdubA0ufGh8nShwzRz5h-lX7cUncYfJxOWN22wnrevYcU6EU8cRLSMs0LCU6TmeaS-Zx5iuW-Ld_iiXwtSrXQKmq_535mAkzvWUXI54yXb_UK_bjy-eH27vm_vvXb7cf7xunW6OaXhitvXLYWm9GNEi9GhVS1w-jHHzXk9E4CBRjNyhUXnRHoS0aa1GP1I76ir17_ltCpIngcdnSXA1BCthxwY4LhIQdV1X7Z3V2AUvBjRKsKVYiv-Elb44ZKgcISNOSC-6zW-aypwZMLsQzQcx5I8gruRoZJpy37CqKArI_trLazP_BBnJYniCU6aT_AJehs8o</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>D-dimer as a marker for cardiovascular and arterial thrombotic events in patients with peripheral arterial disease</title><source>Thieme Connect Journals</source><creator>M.-C. F. Kleinegris ; H. ten Cate ; A. J. ten Cate-Hoek</creator><creatorcontrib>M.-C. F. Kleinegris ; H. ten Cate ; A. J. ten Cate-Hoek</creatorcontrib><description>Peripheral artery disease (PAD) is associated with an increased risk for cardiovascular events. D-dimers are a marker for hypercoagulability and are linked with thrombotic events in patients with venous as well as arterial thrombosis. The predictive value of plasma D-dimer levels in relation to cardiovascular events in patients with PAD is not unambiguously established. It was our objective to gather evidence evaluating the value of D-dimer as a predictor of arterial thrombotic events patients with PAD. The Pubmed, Embase, and Cochrane databases were searched (January 1980-November 2012), and 65 abstracts were found. The strategy was supplemented with manual review of reference lists. Case-control, cohort or prospective cohort studies that measured fibrin D-dimer in patients with PAD, were included. Studies were excluded if there was no follow-up for arterial thrombotic events or when no specific information on D-dimer was available. The search yielded 10 studies for our analysis, comprising 2,420 patients with PAD, with a total of 1,036 cardiovascular events in 10,599 patient-years. Two studies with a follow-up of one year showed that fibrin D-dimer predicts both deterioration of PAD and subsequent thrombotic events. Five out of six studies with a median follow-up of 2–4 years revealed that an increased D-dimer is predictive of various arterial thrombotic events including mortality. Two studies with a longer follow-up (over 6 years) did not show an independent association between increased D-dimer levels, arterial thrombotic events and CVD mortality. In conclusion, an increased D-dimer appeared to be independently associated with a two times increased risk of near-term cardiovascular events (relative risk 2.30, 95% confidence interval 1.43–3.68). However formal meta-analysis was only feasible for four out of 10 included studies. Due to the extended heterogeneity of the included studies cautious interpretation of these data is warranted.</description><identifier>ISSN: 0340-6245</identifier><identifier>EISSN: 2567-689X</identifier><identifier>DOI: 10.1160/TH13-01-0032</identifier><language>eng</language><publisher>Schattauer Verlag für Medizin und Naturwissenschaften</publisher><subject>arterial thrombotic events ; D-dimer ; fibrin degradation products ; intermittent claudication ; Peripheral arterial disease ; Review Article</subject><ispartof>Thrombosis and haemostasis, 2013, Vol.110 (2), p.233-243</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3452-90533d2ca46d5fa5ae92f2ae79bf1bd79e53ab0a0f7b2a2d078036a566a3fe4f3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://www.schattauer.de/typo3temp/pics/cover-1768_866f7f7a42.jpg</thumbnail><linktopdf>$$Uhttps://www.thieme-connect.de/products/ejournals/pdf/10.1160/TH13-01-0032.pdf$$EPDF$$P50$$Gthieme$$H</linktopdf><linktohtml>$$Uhttps://www.thieme-connect.de/products/ejournals/html/10.1160/TH13-01-0032$$EHTML$$P50$$Gthieme$$H</linktohtml><link.rule.ids>314,780,784,3018,4024,27923,27924,27925,54559,54560</link.rule.ids></links><search><creatorcontrib>M.-C. F. Kleinegris</creatorcontrib><creatorcontrib>H. ten Cate</creatorcontrib><creatorcontrib>A. J. ten Cate-Hoek</creatorcontrib><title>D-dimer as a marker for cardiovascular and arterial thrombotic events in patients with peripheral arterial disease</title><title>Thrombosis and haemostasis</title><addtitle>Thromb Haemost</addtitle><description>Peripheral artery disease (PAD) is associated with an increased risk for cardiovascular events. D-dimers are a marker for hypercoagulability and are linked with thrombotic events in patients with venous as well as arterial thrombosis. The predictive value of plasma D-dimer levels in relation to cardiovascular events in patients with PAD is not unambiguously established. It was our objective to gather evidence evaluating the value of D-dimer as a predictor of arterial thrombotic events patients with PAD. The Pubmed, Embase, and Cochrane databases were searched (January 1980-November 2012), and 65 abstracts were found. The strategy was supplemented with manual review of reference lists. Case-control, cohort or prospective cohort studies that measured fibrin D-dimer in patients with PAD, were included. Studies were excluded if there was no follow-up for arterial thrombotic events or when no specific information on D-dimer was available. The search yielded 10 studies for our analysis, comprising 2,420 patients with PAD, with a total of 1,036 cardiovascular events in 10,599 patient-years. Two studies with a follow-up of one year showed that fibrin D-dimer predicts both deterioration of PAD and subsequent thrombotic events. Five out of six studies with a median follow-up of 2–4 years revealed that an increased D-dimer is predictive of various arterial thrombotic events including mortality. Two studies with a longer follow-up (over 6 years) did not show an independent association between increased D-dimer levels, arterial thrombotic events and CVD mortality. In conclusion, an increased D-dimer appeared to be independently associated with a two times increased risk of near-term cardiovascular events (relative risk 2.30, 95% confidence interval 1.43–3.68). However formal meta-analysis was only feasible for four out of 10 included studies. Due to the extended heterogeneity of the included studies cautious interpretation of these data is warranted.</description><subject>arterial thrombotic events</subject><subject>D-dimer</subject><subject>fibrin degradation products</subject><subject>intermittent claudication</subject><subject>Peripheral arterial disease</subject><subject>Review Article</subject><issn>0340-6245</issn><issn>2567-689X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNq9kMtqHTEMhk1pIKdpdnkA78u0vow9Z5YlvaQQ6CaF7oTG1mCnZy7YnhP69vU0oY_QlST0Sz__x9iNFO-ltOLDw53UjZCNEFq9YgdlbNfYY__zNTsI3YrGqtZcsjc5PwohbdubA0ufGh8nShwzRz5h-lX7cUncYfJxOWN22wnrevYcU6EU8cRLSMs0LCU6TmeaS-Zx5iuW-Ld_iiXwtSrXQKmq_535mAkzvWUXI54yXb_UK_bjy-eH27vm_vvXb7cf7xunW6OaXhitvXLYWm9GNEi9GhVS1w-jHHzXk9E4CBRjNyhUXnRHoS0aa1GP1I76ir17_ltCpIngcdnSXA1BCthxwY4LhIQdV1X7Z3V2AUvBjRKsKVYiv-Elb44ZKgcISNOSC-6zW-aypwZMLsQzQcx5I8gruRoZJpy37CqKArI_trLazP_BBnJYniCU6aT_AJehs8o</recordid><startdate>2013</startdate><enddate>2013</enddate><creator>M.-C. F. Kleinegris</creator><creator>H. ten Cate</creator><creator>A. J. ten Cate-Hoek</creator><general>Schattauer Verlag für Medizin und Naturwissenschaften</general><general>Schattauer GmbH</general><scope/></search><sort><creationdate>2013</creationdate><title>D-dimer as a marker for cardiovascular and arterial thrombotic events in patients with peripheral arterial disease</title><author>M.-C. F. Kleinegris ; H. ten Cate ; A. J. ten Cate-Hoek</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3452-90533d2ca46d5fa5ae92f2ae79bf1bd79e53ab0a0f7b2a2d078036a566a3fe4f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>arterial thrombotic events</topic><topic>D-dimer</topic><topic>fibrin degradation products</topic><topic>intermittent claudication</topic><topic>Peripheral arterial disease</topic><topic>Review Article</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>M.-C. F. Kleinegris</creatorcontrib><creatorcontrib>H. ten Cate</creatorcontrib><creatorcontrib>A. J. ten Cate-Hoek</creatorcontrib><jtitle>Thrombosis and haemostasis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>M.-C. F. Kleinegris</au><au>H. ten Cate</au><au>A. J. ten Cate-Hoek</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>D-dimer as a marker for cardiovascular and arterial thrombotic events in patients with peripheral arterial disease</atitle><jtitle>Thrombosis and haemostasis</jtitle><addtitle>Thromb Haemost</addtitle><date>2013</date><risdate>2013</risdate><volume>110</volume><issue>2</issue><spage>233</spage><epage>243</epage><pages>233-243</pages><issn>0340-6245</issn><eissn>2567-689X</eissn><abstract>Peripheral artery disease (PAD) is associated with an increased risk for cardiovascular events. D-dimers are a marker for hypercoagulability and are linked with thrombotic events in patients with venous as well as arterial thrombosis. The predictive value of plasma D-dimer levels in relation to cardiovascular events in patients with PAD is not unambiguously established. It was our objective to gather evidence evaluating the value of D-dimer as a predictor of arterial thrombotic events patients with PAD. The Pubmed, Embase, and Cochrane databases were searched (January 1980-November 2012), and 65 abstracts were found. The strategy was supplemented with manual review of reference lists. Case-control, cohort or prospective cohort studies that measured fibrin D-dimer in patients with PAD, were included. Studies were excluded if there was no follow-up for arterial thrombotic events or when no specific information on D-dimer was available. The search yielded 10 studies for our analysis, comprising 2,420 patients with PAD, with a total of 1,036 cardiovascular events in 10,599 patient-years. Two studies with a follow-up of one year showed that fibrin D-dimer predicts both deterioration of PAD and subsequent thrombotic events. Five out of six studies with a median follow-up of 2–4 years revealed that an increased D-dimer is predictive of various arterial thrombotic events including mortality. Two studies with a longer follow-up (over 6 years) did not show an independent association between increased D-dimer levels, arterial thrombotic events and CVD mortality. In conclusion, an increased D-dimer appeared to be independently associated with a two times increased risk of near-term cardiovascular events (relative risk 2.30, 95% confidence interval 1.43–3.68). However formal meta-analysis was only feasible for four out of 10 included studies. Due to the extended heterogeneity of the included studies cautious interpretation of these data is warranted.</abstract><pub>Schattauer Verlag für Medizin und Naturwissenschaften</pub><doi>10.1160/TH13-01-0032</doi><tpages>11</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0340-6245 |
ispartof | Thrombosis and haemostasis, 2013, Vol.110 (2), p.233-243 |
issn | 0340-6245 2567-689X |
language | eng |
recordid | cdi_thieme_journals_10_1160_TH13_01_0032 |
source | Thieme Connect Journals |
subjects | arterial thrombotic events D-dimer fibrin degradation products intermittent claudication Peripheral arterial disease Review Article |
title | D-dimer as a marker for cardiovascular and arterial thrombotic events in patients with peripheral arterial disease |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T00%3A32%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-thieme_schat&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=D-dimer%20as%20a%20marker%20for%20cardiovascular%20and%20arterial%20thrombotic%20events%20in%20patients%20with%20peripheral%20arterial%20disease&rft.jtitle=Thrombosis%20and%20haemostasis&rft.au=M.-C.%20F.%20Kleinegris&rft.date=2013&rft.volume=110&rft.issue=2&rft.spage=233&rft.epage=243&rft.pages=233-243&rft.issn=0340-6245&rft.eissn=2567-689X&rft_id=info:doi/10.1160/TH13-01-0032&rft_dat=%3Cthieme_schat%3E10_1160_TH13_01_0032%3C/thieme_schat%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |